Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.740
+0.080 (4.82%)
At close: Aug 13, 2025, 4:00 PM
1.700
-0.040 (-2.30%)
After-hours: Aug 13, 2025, 6:50 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.
Employees
33
Change (1Y)
-14
Growth (1Y)
-29.79%
Revenue / Employee
n/a
Profits / Employee
-$1,682,697
Market Cap
170.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MIST News
- 1 day ago - Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 26 days ago - Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution - Seeking Alpha
- 4 weeks ago - Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Benzinga
- 4 weeks ago - Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants - GlobeNewsWire
- 4 weeks ago - Milestone Pharmaceuticals Announces Proposed Public Offering - GlobeNewsWire
- 4 weeks ago - Milestone Pharmaceuticals Announces FDA Acceptance of the Company's Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray - GlobeNewsWire
- 5 weeks ago - Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst - Seeking Alpha
- 2 months ago - Milestone Pharmaceuticals Submits Response to the FDA's CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting - GlobeNewsWire